Severe myoclonic epilepsy of infancy (SMEI, also known as Dravet syndrome) and genetic epilepsy with febrile seizures plus (mild febrile seizures) can both arise due to mutations of SCN1A, the gene encoding alpha 1 poreforming subunit of the Nav1.1 voltage-gated sodium channel. Owing to the inaccessibility of patient brain neurons, the precise mechanism of mild febrile seizures and SMEI remains elusive, and there is no effective pharmacotherapy. Induced pluripotent stem cells (iPSCs) and induced neurons (iNs) have been successfully generated from patients and applied for modeling various neuronal diseases. In this study, we established iPSC lines from one SMEI patient and one mild febrile seizures patient, respectively. Functional glutamatergic neurons were subsequently differentiated from these iPSCs. Electrophysiological analysis of patient iPSCderived glutamatergic neurons revealed a hyperexcitable state of enlarged and persistent sodium channel activation, more intensive evoked action potentials and typical epileptic spontaneous action potentials. In consistent with the severity of the symptoms, the hyperexcitability of the neurons derived from SMEI patient was more serious than that of mild febrile seizures patient. Furthermore, the hyperexcitability of the neurons can be alleviated by treatment with phenytoin, a conventional antiepileptic drug. In parallel, iNs were directly converted from patient fibroblasts which also showed a delayed inactivation of sodium channels. Our results demonstrate that both iPSC-derived neurons and iNs from mild febrile seizures and SMEI patients exhibited a hyperexcitable state. More importantly, patient iPSC-derived neurons can recapitulate the neuronal pathophysiology and respond to drug treatment, indicating that these neurons can be potentially used for screening appropriate drugs for personalized therapies.
INTRODUCTION
More than 70% occurrence of genetic epilepsy with febrile seizures plus (mild febrile seizures) and severe myoclonic epilepsy of infancy (SMEI) (also known as Dravet syndrome) arise due to de novo mutations of SCN1A, the gene encoding alpha 1 poreforming subunit of the Nav1.1 voltage-gated sodium channel.
convulsive disorder that is characterized by febrile seizures with onset during the first year of life followed by intractable epilepsy, impaired psychomotor development and ataxia (3, 4) , and SMEI is typically resistant to standard anticonvulsant pharmacotherapy.
Exploration of the pathological mechanism of mild febrile seizures and SMEI was difficult due to the inaccessibility of patient brain neurons. Previous studies using SCN1A knockout mouse models suggested that reduced sodium current in GABAergic interneurons might be the cause of SMEI (5) . However, another report detected persistent, non-inactivating sodium channel behavior in immortalized cell lines expressing a mutated SCN1A gene (6) . Thus, the exact pathological mechanism of mild febrile seizures and SMEI remains elusive.
Induced pluripotent stem cells (iPSCs) and directly induced neurons (iNs) provide us a direct tool to explore the mechanism of mild febrile seizures and SMEI, which can circumvent the problems raised by divergence between cell types and species. iPSCs can be generated from differentiated somatic cells by ectopic expression of the transcription factors Oct4, Sox2, Klf4 and c-Myc (OSKM) (7 -12) . The generation of patientspecific iPSC lines has attracted great attention because iPSCs can potentially be used for cell-based therapies (13) (14) (15) . iPSCs have already provided a tool for modeling diseases in vitro, exploring their pathology and screening for appropriate drugs (16) (17) (18) (19) (20) . Inspired by iPSC reprogramming technology, direct conversion of one differentiated cell type to another has been achieved through ectopic expression of cell-specific transcription factors. To date, direct conversion from fibroblasts has been achieved for neurons, hepatocytes and cadiomyocytes (21) (22) (23) . Moreover, the functionality of the converted cells has been verified by in vivo transplantation and in situ transdifferentiation (24) . By taking advantage of iPSCs and iNs, many neuronal diseases such as Alzheimer's disease, Parkinson's disease, Rett syndrome and schizophrenia have been successfully recapitulated in vitro (25) (26) (27) (28) .
In this study, we reported Q1923R and F1415I missense mutations in mild febrile seizures patient and SMEI patient, respectively. We produced SMEI and mild febrile seizures patient-specific iPSCs and then differentiated the iPSCs into glutamatergic neurons, which generated action potentials and formed functional excitatory synapses. Biophysical characterization of the patientderived neurons demonstrated that patient iPSC-derived neurons showed enlarged amplitude and delayed inactivation of voltage-gated sodium channels. Furthermore, SMEI and mild febrile seizures patient iPSC-derived neurons showed spontaneous action potentials with epileptic characteristics, representing a hyperexcitable state. Importantly, treatment of SMEI neurons with antiepileptic drug phenytoin alleviated the enlargement and persistence of sodium channels and eliminated the epilepticform action potentials. In parallel, we generated iNs directly from patient fibroblasts. Patient-specific iNs also showed delayed inactivation of sodium channels.
RESULTS

Derivation of iPSC lines from SMEI and mild febrile seizures patient fibroblasts
Skin fibroblasts were cultured from one patient who was diagnosed with SMEI, one patient with the mild classical febrile epilepsy and an unaffected control. The SCN1A gene was cloned from the genomic DNA of these two patients and the unaffected control. Subsequent sequencing of SCN1A revealed that SMEI patient has a missense mutation F1415I, which located in the linker domain of S3 and S4 domain, and the Q1923R mutation was detected in the mild febrile seizures patient, which located in the C-terminal ( Fig. 1A; Supplementary Material,  Fig. S1 ).
To generate iPSC lines, fibroblasts were infected with retroviruses carrying four factors: OCT4, SOX2, KLF4 and C-MYC. As expected, round, flattened colonies appeared after 2 weeks and became compact after 1 month. Human embryonic stem cell (hESC)-like colonies were then picked and passaged manually. The iPSC lines showed typical morphology of hESCs (Fig. 1B) . Most iPSC lines maintained normal karyotype ( Fig. 1C; Supplementary Material, Fig. S2 and Table S1 ). They expressed pluripotency markers including OCT4, NANOG, SOX2 and surface markers, such as TRA-1-60 and TRA-1-81 ( Fig. 1D; Supplementary Material, Fig. S3 ). Microarray analysis showed that the global gene expression profile of iPSC lines is similar to that of hESCs, but distinct from that of human fibroblast cells (Fig. 1E) . In vivo differentiation ability of SMEI and mild febrile seizures patient-specific iPSC lines was assessed using teratoma formation assay. Teratomas-containing cells derived from the three embryonic germ layers were observed in NOD/SCID mice ( Fig. 1F ; Supplementary Material, Fig. S4 and Table S1 ). With the criteria of right karyotype, pluripotent genes expression, capability of generating three germ layers in teratoma, two iPSC lines from the Q1923R patient, two iPSC lines from the F1415I patient and two iPSC lines generated from unaffected human fibroblasts were selected for further experiments of neuron differentiation and electrophysiological examinations (Supplementary Material, Table S1 ). Collectively, these results showed that pluripotent iPSC lines could be generated from mild febrile seizures and SMEI patient fibroblasts.
SMEI and mild febrile seizures iPSCs can be differentiated into mature functional glutamatergic neurons in vitro
We next intended to differentiate the selected iPSCs into neurons as previously described (29) . The neurons differentiated from iPSCs (diN for short) through embryoid body (EB) exhibited typical neuronal morphology and expressed pan-neuronal markers TUJ-1 and MAP2 ( Fig. 2A ; Supplementary Material, Fig. S5 and S6A ). The differentiation efficiency of patient iPSCs and control iPSCs was comparable (Supplementary Material, Fig. S6B ). Electrophysiological test showed that the cells gained resting membrane potentials between 245 and 260 mV and were indistinguishable among cell lines (Supplementary Material, Fig. S7A ). Furthermore, the neurons showed sodium channel activities and the action potentials can be eliminated with tetrodotoxin (TTX) treatment ( Fig. 2B and C) .
When co-cultured with human astrocytes, the neurons formed functional synapses reflected by the expression of Synapsin and miniature excitatory post-synaptic currents recorded in patch clamp ( Fig. 2D and E) . This indicated that the differentiated neurons could integrate into neural circuit in vitro. Further characterization of the neurons showed that 90% of the neurons were glutamatergic neurons and the rest were GABAergic neurons (Fig. 3A) . These results indicate that successful differentiation of SMEI and mild febrile seizure patient-specific iPSCs into functional glutamatergic neurons can be achieved.
Glutamatergic neurons derived from SMEI iPSCs displayed enlarged sodium currents and delayed inactivation of sodium channel
In order to decipher the pathological mechanism of SMEI and mild febrile seizures, we next examined the electrophysiological properties of voltage-gated sodium channels in neurons differentiated from the SMEI and mild febrile seizures patient iPSCs.
In the voltage clamp mode, current -voltage relationships of the wild-type and patient-specific iPSC-derived neurons were examined. We marked the cells recorded in patch clamp with biocytin and further characterized them by immunohistochemistry identification after patch-clamp experiment. Since 90% of the iPSC-derived neurons were glutamatergic neurons (Fig. 3A) , all neurons recorded expressed VGLUT1 indicating their identities (Fig. 3B) . The I -V curve reflected apparently enlarged magnitude of sodium currents in the neurons from SMEI and mild febrile seizures patients with different extent: sodium currents in SMEI showed more severe enlarged sodium currents and mild febrile seizures showed relatively less severe enlargement (Fig. 3C) .
Besides the magnitude of the sodium currents, sodium channel inactivation of the iPSC-derived neurons of the F1415I and Q1923R were apparently delayed in the voltage clamp (Fig. 3C) . Normalized current -voltage relationship and inactivation of the differentiated neurons were further examined. First, sodium currents were normalized to the maximum sodium current, respectively, to show the inactivation of sodium channel. Normalized I-V curves from sodium channels showed that the reverse potential of F1415I neurons significantly shifted to depolarization and reverse potential of Q1923R neurons slightly shifted to depolarization. Therefore, current-voltage relationships for sodium channels showed incomplete inactivation in the F1415I iPSC-derived neurons, and relatively minor incomplete inactivation of sodium channels in Q1923R iPSC-derived neurons was observed (Fig. 3D) . The inactivation of sodium channels was further examined in differentiated neurons derived from the F1415I patient iPSCs, Q1923R patient iPSCs and control iPSCs. The V50 value for inactivation in control cells was 259 + 0.35 mV (n ¼ 17). In contrast, significant depolarizing shifts in the inactivation curves were detected in F1415I iPSC-derived neurons (V50: 236.63 + 0.72 mV, n ¼23), and relative minor impairment of inactivation of sodium channels was observed in Q1923R mild febrile seizures patient iPSC-derived neurons (V50 ¼ 247.61 + 0.60 mV, n ¼ 19) ( 
Neurons derived from SMEI and mild febrile seizures iPSCs displayed alterations in action potential characteristics
In consistent with the sodium channel activity data, action potentials evoked following depolarizing current injection of SMEI and mild febrile seizures iPSC-derived neurons had apparently larger amplitude and higher frequencies (Fig. 4A) . Further analysis on the amplitude of the action potentials showed significant enlargement in the F1415I neuron, whereas the Q1923R showed similar amplitude as wild-type cells (Fig. 4B) . Furthermore, we examined the numbers of action potentials evoked by injection of currents. F1415I neurons showed significant more action potentials than the wild-type cells, and Q1923R neurons showed slightly more action potentials than the control cells (Fig. 4C ). These results indicate that, in accordance with the enlarged and sustained activated sodium currents, neurons of the SMEI patient showed larger and more action potentials, whereas mild febrile seizures neurons showed less severe phenotype. Taken together, the results demonstrated that SMEI patient iPSC-derived glutamatergic neurons showed hyperexcitability.
Neurons differentiated from SMEI and mild febrile seizures patient iPSCs showed epileptiform discharges
We next examined whether the SMEI and mild febrile seizures iPSC-derived neurons can recapitulate the epileptic phenotype. Spontaneous action potentials showed higher frequency in the F1415I and Q1923R neurons than wild-type with different extent, and typical epileptic firing was detected in a portion of iPSC-derived neurons obtained from F1415I and Q1923R patients (Fig. 5 ). The frequencies of action potential of F1415I were 5 Hz, which is significantly higher than the wild-type cells of 2 Hz, and the Q1923R neurons showed moderate frequencies of 3-4 Hz ( Fig. 5A and B) .
Besides the higher frequencies observed, epileptic firing characterized by action potentials with amplitudes of 50 mV and firing frequencies of .5 Hz was identified in some neurons of F1415I and Q1923R (Fig. 5) . These action potentials showed paroxysmal depolarization shifts (PDSs) featured with elongated repolarization times, deep cuneiform waveforms and enlarged wave widths (Fig. 5C ). These observations demonstrate that SMEI and mild febrile seizures patient iPSC-derived neurons recapitulated the abnormal sodium currents, action potentials and epileptiform firing.
Treatment of SMEI patient neurons with phenytoin can alleviate the hyperexcitability
We next sought to investigate whether the patient iPSCdifferentiated neurons can respond to the drug used for treating epilepsy. When treated with phenytoin (100 mM), a traditional antiepileptic drug, in perfusion system of patch clamp, the SMEI iPSC-derived neurons showed reduced sodium currents and alleviated delayed inactivation of sodium channel (Fig. 6A) . Accordingly, the stimulated action potentials by injection of current steps reduced in frequency and amplitude (Fig. 6B) . Moreover, the epileptic form of the spontaneous action potentials disappeared upon phenytoin treatment (Fig. 6C) . These results indicate that the iPSC-derived neurons can respond to antiepileptic drug and can be potentially applied in drug screening in the future.
Direct conversion of SMEI and mild febrile seizures patient fibroblasts to functional glutamatergic neurons
To generate iNs from fibroblasts directly, fibroblasts from the two patients and the unaffected control were infected with lentiviruses carrying six transcription factors including ASCL1, BRN2, MYT1Ll, NEUROD1, OLIG2 and ZIC1 (26) in the presence of neural survival factors BDNF, GDNF and NT3. One month after Fig. S8A ). No significant differences in the kinetics or the efficiency of conversion from fibroblasts to neurons were detected. The neuron-like cells expressed panneuronal markers such as TUJ-1, MAP2 and NEUN. Approximately half of the iNs were positive for the mature glutamatergic neuron marker VGLUT1, and very few iNs expressed the mature GABAergic neuron marker GAD67 (Fig. 7A) .
We further assessed the physiological properties of the iNs with patch-clamp recordings at days 25-35 of culture. We found that majority of iNs displayed typical neuronal Na + and K + channels properties (Fig. 7B) . Moreover, single and multiple action potentials could be evoked with a series of depolarizing current injections in most iNs (Fig. 7C) . However, the resting membrane potential of the iNs was around 230 mV, indicating an immature state (Supplementary Material, Fig. S8B ). Owing to the extremely low conversion efficiency (,1%, Supplementary Material, Fig. S8A ), the miniature EPSCs were not detected in the iNs. The analysis of properties of evoked action potentials and spontaneous action potentials was prevented by the immature state of the iNs. These results demonstrate that we can directly convert SMEI patient and mild febrile seizures patient fibroblasts into neurons possessing basic function.
SMEI and mild febrile seizures patient converted neurons showed delayed inactivation of sodium channels Physiological properties of the converted neurons from SMEI and mild febrile seizures patients and the unaffected control were studied under identical conditions using whole-cell patchclamp recordings. Figure 8A illustrated the representative whole-cell currents from iN cells converted from the patient cell lines and the unaffected control. In general, the F1415I SMEI iNs exhibited rapid activation which was similar to control iNs. However, F1415I iNs had impaired inactivation properties ( Fig. 8A and B) . Sodium channels of iNs from the F1415I patient displayed delayed inactivation compared with the control, whereas neurons from the Q1923R mild febrile seizures patient displayed no obvious differences from the control. In all cases, sodium channels were confirmed to be TTX-sensitive (Fig. 8C) .
We further examined the electrophysiological properties of sodium channels in neurons converted from SMEI patient fibroblasts. Current -voltage relationships and voltage dependence of activation and inactivation of the differentiated neurons were examined. We observed obvious delays in the inactivation of sodium channels for F1415I iNs, so we decided to test the current -voltage relationship first. I -V curves from F1415I sodium channels showed reverse potential shifts to depolarization when compared with the control. Similar to the results obtained in the iPSC-derived neurons, current-voltage relationships of sodium channels showed delayed inactivation in iNs converted from F1415I fibroblasts (Fig. 8D) .
The inactivation of sodium channels was examined in converted neurons from F1415I and Q1923R patients as well as the control. In F1415I patient neurons, inactivation curves were shifted in the depolarized direction. In Q1923R patient neurons, this shift was less noticeable (Fig. 8E) . The V50 value for inactivation in control iNs was 258.65 + 0.48 mV (n ¼ 21). Significant depolarization shifts in the inactivation curves were detected for F1415I iNs (V50: 251.02 + 2.05 mV, n ¼ 23) and Q1923R (V50: 255.37 + 0.99 mV, n ¼ 25). These results indicate a delayed inactivation of voltage-gated sodium channels in F1415I and Q1923R iNs, which is similar to the results obtained with iPSC-derived neurons. Collectively, these results demonstrate that delayed inactivation of sodium channels can be detected in directly converted neurons from SMEI patient fibroblasts, and relative minor impairment of sodium channels was observed in directly converted neurons from mild febrile seizures patient fibroblasts.
Comparison between the two methods in obtaining patientspecific neurons revealed that the percentage of neurons differentiated from the iPSCs was .80%, whereas the percentage of iNs was ,1% (Supplementary Material, Fig. S8A ). Furthermore, the neurons derived from iPSCs possessed resting membrane potentials around 255 mV, which is comparable with neurons in brain slices, whereas the resting membrane potentials of iNs is around 230 mV, indicating an immature state (Supplementary Material, Fig. S8B ). The results demonstrated that although the derivation of neurons from iPSCs takes longer ( 3 months from human fibroblasts) than direct conversion from fibroblasts ( 1 month), neurons derived from iPSCs exhibit higher efficiency and better maturation.
DISCUSSION
The pathophysiology of seizures is believed to be an alteration in the normal balance of inhibition and excitation. A hyperexcitable state of neuronal network which causes seizures can result from increased excitatory synaptic neurotransmission and/or decreased inhibitory neurotransmission. The major excitatory neurotransmitter is glutamate and the major inhibitory neurotransmitter is GABA. Hyperexcitability of glutamatergic neurons and/or hypoexcitability of GABAergic neurons results in the hyperexcitability of the neuronal network (30) .
Several approaches have been developed to investigate the pathological mechanism of SMEI. Expression of mutated genes in cell lines provided an in vitro tool to study the ion channel properties (31, 32) . Investigations with the cell lines transfected with the mutated SCN1A found delayed inactivation of sodium currents. However, although the transfected cell lines possessed ion channels on their cell membranes, they were not capable of recapitulating neuronal phenotypes and functions. Knockout mouse models have been widely used to model epilepsy in vivo (5). The mouse model possessed the neuronal circuit that is disrupted in SMEI and reflected the disease phenotype in some aspects. Knockout mouse model showed reduced sodium currents in the GABAergic neurons. However, mouse models are limited because of discrepancies between mice and humans in terms of disease progression and the underlying disease mechanisms. To date, the precise mechanism of SMEI remains controversial and elusive.
The development of iPSCs provides a revolutionized approach to investigate the pathological mechanism of many diseases, especially neuronal diseases. We demonstrated the modeling of SMEI, using functional neurons obtained using iPSC technology and technology for direct conversion of fibroblasts to neurons. Further analysis on the sodium channels of the neurons revealed delayed inactivation in iPSC-derived neurons from a patient with an F1415I mutation. Moreover, examination of the spontaneous firing of iPSC-derived neurons from patients showed action potentials typical of epilepsy. The abnormal firing observed in epileptic neurons could be reproduced by in vitro modeling of the neurons differentiated from the patient iPSCs.
At present, two models have been proposed to interpret the pathological mechanism of SMEI. In the first model, loss of function in the SCN1A genes causes reduced sodium current in inhibitory GABAergic neurons, leading to insufficient inhibition, hyperexcitability in the neuronal network and epilepsy (5) . The second model proposes a gain-of-function mutation in which persistent activation of sodium currents leads to hyperexcitability in neurons, causing epilepsy (6) . Based on the diversity of the mutations in SCN1A in SMEI patients, different pathological mechanisms might be responsible for a common epileptic phenotype. An explanation for inconsistencies in previous studies is that various mutations change the conformation of the SCN1A protein in various ways, resulting in diverse functional consequences. Here, we observed a gain-of-function effect for both F1415I and Q1923R mutations reflected by the epileptiform discharges from iPSC-derived neurons. A change in electrophysiological behavior of sodium channels was the major cause of the epileptic phenotype with the F1415I mutation but was relatively minor for the Q1923R mutation. The results are in accordance with the different locations of the mutation on SCN1A. The mutation lies in the linker domain between S5 and S6 in SMEI patient, which is critical for the formation of pore, and lies in the C terminal in mild febrile seizures patient, which is considered to be less important (Supplementary Material, Fig. S1 ) (33) . Our results indicate that at least a portion of SMEI patients may have persistent sodium channel activation that causes neurons to become hyperexcitable. Moreover, the severity of impairment of sodium channels in the two patients is consistent with the severity of the symptoms.
Phenytoin is considered to inhibit seizure by decreasing highfrequency repetitive firing of action potentials through enhancing sodium channel inactivation (34) . Here, we applied phenytoin to the SMEI iPSC-derived neurons. Reduced sodium currents and action potentials were detected and also the epileptic firing was eliminated. The results demonstrated that the neurons derived from iPSCs can respond to antiepileptic drug and thus could be used for drug screening.
Both iPSC-derived neurons and directly converted neurons have been utilized in disease modeling. In this study, we used both approaches to generate functional neurons from one SMEI patient and one mild febrile seizures patient, and consistent phenotypic and electrophysiological results were obtained. The technology for iPSC generation and neuron differentiation is well established and has high efficiency (.80%) for neuron differentiation. Compared with iPSC technology, the efficiency for generating directly converted neurons remains very low (,1%). We also found that the iNs in this experiment possessed higher resting membrane potential, indicating the immature state of the neuron. However, this technology can significantly shorten the period of time required for generating functional neurons from fibroblasts.
In conclusion, we obtained functional neurons from the differentiation of SMEI patient-specific iPSCs and from the direct conversion of mild febrile seizures and SMEI patient fibroblasts. The iPSC-derived neurons revealed mild-to-severe hyperexcitability in the glutamatergic neurons of mild febrile seizures and SMEI patients; and also recapitulated the typical epileptic phenotype; and could respond to an antiepileptic drug. These neurons reveal that SMEI and mild febrile seizures arise due to the altered firing of glutamagergic neurons, more importantly, can potentially be applied for screening appropriated drugs for personalized clinical treatment of SMEI.
MATERIALS AND METHODS
Mutation detection
Genomic DNAs of fibroblasts from patients and patient-specificiPSCs were extracted with the Tissue and Cells Genomic DNA Extraction Kit (Biomed) following the instructions provided by the producer. Each exon of the SCN1A was cloned from the genomic DNA with PCR. Phusion DNA polymerase (Thermo scientific) was utilized in the amplification reaction following the instructions of the producer. Sequences of primers of each exon were described previously (2) . Amplification products were sequenced with Sanger method (conducted in Invitrogen Co.). The numbering of the mutation was started from the ATG codon of the coding sequence of SCN1A.
SMEI and mild febrile seizures patient-specific iPSC line derivation
Fibroblasts collected from SMEI patients containing the F1415I mutation and mild febrile seizures patients containing Q1923R mutation were utilized for iPSC induction. Plasmids (pMIG) containing human OSKM were obtained from Addgene and were transiently co-transfected with package plasmids into 293 T cells, using the Vigofect transfection reagent (Vigorous). Viral supernatants were harvested after 48 h, filtered through a 0.45 mm low protein-binding cellulose acetate filter (Millipore) and concentrated by centrifugation. A total of 5 × 10 4 fibroblasts from each patient were incubated with virus for 24 h and then seeded onto irradiated mouse embryonic fibroblasts (MEFs) feeder cells and cultured for 5 days. iPSC culture medium was substituted after 7 days. iPSC colonies were manually picked and mechanically dissociated for the next passage.
iPSC maintenance SMEI patient-specific iPSCs and control human ES cell lines were cultured on irradiated ICR MEF feeders, using the following culture medium: DMEM/F12 (1:1) medium (Invitrogen) containing 20% knockout serum replacement (Invitrogen), 1 mM non-essential amino acids (Invitrogen), 3 mM L-glutamine (Invitrogen), 0.1 mM b-mercaptoethanol (Sigma-Aldrich), 100 U/ml penicillin, 100 mg/ml streptomycin (Invitrogen) and 8 ng/ml bFGF (R&D Systems). iPSCs and hESCs were either passaged mechanically or passaged with 1 mg/ml collagenase IV (Sigma-Aldrich).
Karyotype analysis
The iPSCs were incubated in culture medium containing 0.25 mg/ml colcemid (Invitrogen) for 4 h and were then harvested and incubated in hypotonic solution containing 0.4% sodium citrate and 0.4% kalium chloratum (1:1, v/v) at 378C for 5 min, before fixation with three washes of a mixture of methanol:acetic acid (3:1, v/v). Slides were aged for 8 -12 h at 658C and digested with 0.8% trypsin for 15-30 s. Slides were then stained with Giemsa for 10 min and air-dried. Twenty metaphase chromosome karyoschisis images were examined, and 5 G-band images were analyzed.
Neural differentiation of SMEI patient-specific iPSCs SMEI and mild febrile seizures patient-specific iPSCs and hESCs were passaged with collagenase, and cell clumps were cultured on low attachment plates (Costar) in iPSC culture medium without bFGF. The medium was replaced every 2 days and gradually changed to EB culture medium (DMEM supplemented with 20% fetal bovine serum, 1× non-essential amino acid, 50 mM b-mercaptoethanol, 100 U/ml penicillin and 100 mg/ml streptomycin) by substituting 25% more of the ES medium with EB medium each time the medium was replaced. After 10 days, the EBs in suspension were collected and plated on PDL/laminin-coated plates in neural rosettes medium (DMEM/F12 supplemented with 1× N2, 100 U/ml penicillin and 100 mg/ml streptomycin) with 25 ng/ml bFGF (Peprotech). After 10 -12 days, rosettes were manually picked and plated on PDL/laminin-coated plates in neural rosettes medium. The first passage was performed with 0.05% trypsin/ EDTA (Invitrogen), and the following passages were performed with Accutase (Sigma). Neuronal differentiation was induced by changing the neural rosettes medium to neuron culture medium consisting of Neurobasal (Invitrogen) supplemented with 1× B27 (Invitrogen), 10 ng/ml BDNF (Peprotech), 10 ng/ml GDNF (Peprotech), valproic acid (10 mM, Sigma), insulin-like growth factor 1 (IGF-1, 10 ng/ml, Peprotech), cAMP (1 mM, Sigma), 10 ng/ml NT3 (Peprotech), 100 U/ml penicillin and 100 mg/ml streptomycin. The neuron medium was refreshed every 2 to 3 days. The cells were cultured in neuron medium on human astrocytes layer (Sciencell) for more than 1 month to obtain full maturation.
Direct conversion of SMEI patient fibroblasts to neurons
SMEI patient fibroblasts were cultured in fibroblast culture medium (DMEM with 10% FBS, 1× glutamine, 100 U/ml penicillin and 100 mg/ml streptomycin). Plasmids (pFUW containing ASCL1, BRN2, MYT1L, NEUROD1, OLIG2, ZIC1 and rtTA; obtained from Addgene) were transiently co-transfected with package plasmids into 293 T cells, using Vigofect transfection reagent (Vigorous). Viral supernatants were harvested after 48 h, filtered through 0.45 mm low protein-binding cellulose acetate filters (Millipore) and concentrated by centrifugation. A total of 5 × 10 4 fibroblasts from each patient were incubated with virus for 6 -8 h. After virus infection, cells were cultured in fibroblast culture medium with 1 mg/ml doxycycline for 2 days. The medium was then changed to neuron culture medium with 1 mg/ml doxycycline, and the resulting neurons were maintained in culture on human astrocytes layer for more than 1 month.
Immunofluorescent staining
For immunofluorescent staining, patient fibroblasts or neural progenitor cells derived from iPSCs or ES cells were plated onto PDL-coated glass coverslips. After induction by viral infection or differentiation for 30 days, the cells were fixed overnight at 48C in 4% paraformaldehyde (Sigma) in PBS, permeabilized for 15 min in PBS containing 0.5% Triton X-100, blocked with 5% BSA for 1 h at room temperature and incubated overnight at 48C in PBS containing 1.25% BSA with the primary antibodies. Cells were then washed three times with PBS and incubated for 1 h at room temperature with anti-rabbit or anti-mouse secondary antibodies [Alexa Fluor-488, Alexa Fluor-594 or Alexa Fluor-633 (1:500, Invitrogen)]. The primary antibodies were as follows: rabbit anti-b-III-Tubulin (Tuj-1) (1:1000, Covance), mouse anti-MAP2A (1:500, Millipore), mouse anti-NEUN (1:300, Millipore), rabbit anti-VGLUT1 (1:1000, Synaptic Systems), mouse anti-GAD67 (1:1000, Millipore), mouse anti-SYNAPSIN (1:300, Millipore), mouse anti-OCT4 (1:500, Santa Cruz Biotechnology), mouse anti-SOX2 (1:500, Santa Cruz Biotechnology), rabbit anti-NANOG (1:100, Reprocell), mouse anti-TRA-1 -60 (1:100, Millipore), mouse anti-TRA-1-81 (1:100, Millipore), and FITC-streptavidin (1:1000, Bioscience).
Teratoma formation
Pluripotent cells were harvested by collagenase IV treatment, collected in tubes and centrifuged, and the pellets were suspended in DMEM/F12. Cells from one 60 mm dish were injected subcutaneously into the dorsal flank of a recipient NOD/SCID mouse (Jackson Laboratory). Paraffin sections of formalin-fixed teratoma specimens were prepared 9 weeks after injection. Analysis of H&E-stained tissue sections was performed for each specimen.
Electrophysiology
Electrophysiological experiments were performed using directly converted iNs and iPSC-derived neurons. Whole-cell patchclamp recordings in either voltage or current clamp mode were conducted to measure voltage-activated sodium/potassium currents and action potentials. An EPC-10 (HEKA) amplifier was used for recording the electrophysiological signals. Data were acquired using the Patchmaster software (HEKA) and analyzed using Igor pro (Wavemetrics). Glass micropipettes (2.0 -4.0 MV) containing a solution of 130 mM K+-gluconate, 20 mM KCl, 10 mM HEPES, 0.2 mM EGTA, 4 mM Mg 2 ATP, 0.3 mM Na 2 GTP, 10 mM Na 2+ -phosphocreatine (at pH 7.3, 290-310 mOsm) and 1% biocytin (Invitrogen) were used for patch-clamp recordings. The bath solution contained 140 mM NaCl, 5 mM KCl, 2 mM CaCl 2 , 2 mM MgCl 2 , 10 mM HEPES and 10 mM glucose (at pH 7.4). All electrophysiological experiments were performed at room temperature.
Microarray analysis
Total RNA was extracted from SMEI patient fibroblasts, and SMEI iPSCs and H9 hESCs after induction using Trizol reagent (Invitrogen). Affymetrix GeneChip w Human Genome U133 plus 2.0 (Affymetrix, Inc.) was used, and all experiments were performed at Beijing Capitalbio Corporation. Data were analyzed using the GCOS 1.4 software provided by Affymetrix. Signal values of probes presented in two samples were plotted in a scatter graph. Pearson's correlation coefficient (R) between samples was calculated using Excel. The microarray data sets have been deposited in NCBI's Gene Expression Omnibus under accession number GSE46472. 
